MMC CMO granted options and RSUs

Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received new equity awards.

Rhea-AI Filing Summary

Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received new equity awards. On February 24, 2026 he was granted 15,536 stock options, which vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

He also acquired 4,826 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both instruments convert into Marsh & McLennan common stock on a 1‑for‑1 basis.

Insider Trade Summary

Grant/Award: 20,362 shares

Grant/Award 2 txns

Insider Jones John Jude

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	15,536	$0.00	$0.00
Grant/Award	Restricted Stock Units	4,826	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to Buy) — 15,536 contracts (Direct); Restricted Stock Units — 4,826 contracts (Direct)

Footnotes (4)

1. F1. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24th of 2027, 2028, 2029 and 2030.
2. F2. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
3. F3. These restricted stock units relate to performance stock units that were granted on February 23, 2023 for the performance period 2023-2025. The performance factor for these performance stock units was determined on February 24, 2026.
4. F4. Not applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did MMC CMO John Jude Jones report?

MMC Chief Marketing Officer John Jude Jones reported equity awards, not open-market trades. He received 15,536 stock options and 4,826 restricted stock units, all linked to Marsh & McLennan common stock on a 1-for-1 basis, as part of his compensation package.

When do John Jude Jones’s new MMC stock options vest?

The 15,536 MMC stock options granted to John Jude Jones vest in four equal annual installments. Vesting occurs on February 24 of 2027, 2028, 2029 and 2030, creating a multi-year incentive structure that encourages longer-term alignment with Marsh & McLennan shareholders.

What is the conversion ratio for John Jude Jones’s MMC equity awards?

Both the stock options and restricted stock units convert into Marsh & McLennan Companies common stock on a 1-for-1 basis. This means each option or unit corresponds to one MMC share when vesting or exercise conditions are ultimately satisfied under the award terms.

How are the MMC restricted stock units related to prior performance stock units?

The 4,826 restricted stock units relate to performance stock units granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for those performance stock units was determined on February 24, 2026, resulting in this RSU amount for John Jude Jones.

Did John Jude Jones buy or sell MMC shares on the open market?

The filing shows no open-market buying or selling by John Jude Jones. Instead, it reports equity compensation: a grant of 15,536 stock options and 4,826 restricted stock units awarded with a grant price of zero dollars per unit or option.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:31 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones John Jude

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$176.99	02/24/2026		A		15,536		(1)	02/23/2036	Common Stock	15,536	$0	15,536	D
Restricted Stock Units	(2)	02/24/2026		A(3)		4,826		(4)	(4)	Common Stock	4,826	$0	4,826	D

Explanation of Responses:

1. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24th of 2027, 2028, 2029 and 2030.

2. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.

3. These restricted stock units relate to performance stock units that were granted on February 23, 2023 for the performance period 2023-2025. The performance factor for these performance stock units was determined on February 24, 2026.

4. Not applicable.

	/s/ Tessa Patti, Attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.